Zurich Insurance Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.4M | Buy |
133,106
+43,794
| +49% | +$23.8M | 0.51% | 46 |
|
|
2025
Q4 | $51.8M | Buy |
+89,312
| New | +$50.5M | 0.36% | 76 |
|
|
2024
Q4 | – | Sell |
-84,859
| Closed | -$52.5M | – | 266 |
|
|
2024
Q3 | $52.5M | Sell |
84,859
-135,455
| -61% | -$80.2M | 0.45% | 73 |
|
|
2024
Q2 | $122M | Buy |
220,314
+4,115
| +2% | +$2.36M | 1.06% | 19 |
|
|
2024
Q1 | $126M | Buy |
216,199
+57,145
| +36% | +$32.1M | 1.15% | 19 |
|
|
2023
Q4 | $84.4M | Buy |
+159,054
| New | +$77M | 0.86% | 32 |
|
|
2023
Q2 | – | Sell |
-28,976
| Closed | -$16.7M | – | 263 |
|
|
2023
Q1 | $16.7M | Sell |
28,976
-119,602
| -80% | -$67.4M | 0.21% | 103 |
|
|
2022
Q4 | $81.8M | Sell |
148,578
-12,176
| -8% | -$6.45M | 1.17% | 27 |
|
|
2022
Q3 | $81.5M | Buy |
160,754
+1,924
| +1% | +$1.08M | 1.27% | 21 |
|
|
2022
Q2 | $86.3M | Buy |
+158,830
| New | +$87.4M | 1.28% | 21 |
|
|
2021
Q3 | – | Sell |
-35,447
| Closed | -$17.9M | – | 235 |
|
|
2021
Q2 | $17.9M | Sell |
35,447
-177,465
| -83% | -$83.7M | 0.22% | 73 |
|
|
2021
Q1 | $97.2M | Sell |
212,912
-176,964
| -45% | -$84.5M | 1.39% | 30 |
|
|
2020
Q4 | $182M | Buy |
389,876
+15,146
| +4% | +$7.1M | 2.68% | 8 |
|
|
2020
Q3 | $165M | Sell |
374,730
-46,217
| -11% | -$19.1M | 2.87% | 10 |
|
|
2020
Q2 | $153M | Sell |
420,947
-9,100
| -2% | -$3.05M | 2.59% | 11 |
|
|
2020
Q1 | $122M | Buy |
430,047
+42,809
| +11% | +$13.5M | 2.61% | 10 |
|
|
2019
Q4 | $126M | Buy |
387,238
+303,548
| +363% | +$92M | 2.27% | 8 |
|
|
2019
Q3 | $24.4M | Sell |
83,690
-12,653
| -13% | -$3.62M | 0.46% | 50 |
|
|
2019
Q2 | $28.3M | Buy |
96,343
+10,059
| +12% | +$2.77M | 0.56% | 43 |
|
|
2019
Q1 | $23.6M | Buy |
86,284
+1,925
| +2% | +$479K | 0.5% | 52 |
|
|
2018
Q4 | $18.9M | Buy |
84,359
+2,506
| +3% | +$588K | 0.45% | 63 |
|
|
2018
Q3 | $20M | Buy |
81,853
+20,439
| +33% | +$4.7M | 0.42% | 61 |
|
|
2018
Q2 | $12.7M | Sell |
61,414
-6,658
| -10% | -$1.41M | 0.29% | 91 |
|
|
2018
Q1 | $14.1M | Buy |
68,072
+18,840
| +38% | +$3.95M | 0.32% | 76 |
|
|
2017
Q4 | $9.35M | Buy |
49,232
+6,077
| +14% | +$1.16M | 0.22% | 106 |
|
|
2017
Q3 | $8.16M | Buy |
43,155
+277
| +0.6% | +$50.2K | 0.22% | 107 |
|
|
2017
Q2 | $7.48M | Sell |
42,878
-789
| -2% | -$133K | 0.21% | 110 |
|
|
2017
Q1 | $6.71M | Sell |
43,667
-4,577
| -9% | -$700K | 0.19% | 119 |
|
|
2016
Q4 | $6.81M | Buy |
48,244
+3,718
| +8% | +$548K | 0.22% | 113 |
|
|
2016
Q3 | $7.08M | Sell |
44,526
-7,475
| -14% | -$1.15M | 0.24% | 109 |
|
|
2016
Q2 | $7.68M | Sell |
52,001
-755
| -1% | -$111K | 0.27% | 104 |
|
|
2016
Q1 | $7.47M | Sell |
52,756
-46,128
| -47% | -$6.18M | 0.27% | 100 |
|
|
2015
Q4 | $14M | Sell |
98,884
-46,787
| -32% | -$6.24M | 0.5% | 58 |
|
|
2015
Q3 | $17.8M | Buy |
+145,671
| New | +$19M | 0.66% | 61 |
|
Other funds holding TMO
VCM
Zurich Insurance Group's TMO Position: Q1 2026 in Review
Zurich Insurance Group increased its Thermo Fisher Scientific (TMO) stake by 49% in Q1 2026, buying an estimated $23.8M and bringing the position to 133,106 shares worth $65.4M. The position accounts for 0.51% of the portfolio, ranked #46.
Zurich Insurance Group first reported a position in TMO in Q3 2015 and has held it in 34 quarters since. The position peaked at $182M in Q4 2020. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Zurich Insurance Group held 133,106 shares of Thermo Fisher Scientific worth $65.4M as of Q1 2026.
- Zurich Insurance Group bought 43,794 Thermo Fisher Scientific shares in Q1 2026, an estimated $23.8M.
- Thermo Fisher Scientific made up 0.51% of Zurich Insurance Group's portfolio in Q1 2026, its #46 holding.
- Zurich Insurance Group first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 34 quarters since.
- Zurich Insurance Group's Thermo Fisher Scientific position peaked at $182M in Q4 2020.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.